Your browser doesn't support javascript.
loading
Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial.
Leone, Jose P; Cole, Bernard F; Regan, Meredith M; Thürlimann, Beat; Coates, Alan S; Rabaglio, Manuela; Giobbie-Hurder, Anita; Gelber, Richard D; Ejlertsen, Bent; Harvey, Vernon J; Neven, Patrick; Láng, Istvan; Bonnefoi, Herve; Wardley, Andrew; Goldhirsch, Aron; Di Leo, Angelo; Colleoni, Marco; Vaz-Luis, Ines; Lin, Nancy U.
Afiliación
  • Leone JP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Cole BF; Department of Mathematics and Statistics, University of Vermont, Burlington, Vermont.
  • Regan MM; International Breast Cancer Study Group Statistical Center, Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Thürlimann B; Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Coates AS; International Breast Cancer Study Group and Swiss Group for Clinical Cancer Research, Bern, Switzerland.
  • Rabaglio M; International Breast Cancer Study Group and University of Sydney, Sydney, New South Wales, Australia.
  • Giobbie-Hurder A; International Breast Cancer Study Group Coordinating Center, Bern, Switzerland.
  • Gelber RD; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Ejlertsen B; Swiss Group for Clinical Cancer Research, Bern, Switzerland.
  • Harvey VJ; Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Neven P; Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Láng I; Department of Oncology, Centre for Cancer and Organ Diseases, University of Copenhagen, Copenhagen, Denmark.
  • Bonnefoi H; Regional Cancer and Blood Service, Auckland City Hospital, Auckland, New Zealand.
  • Wardley A; Department of Oncology, Universitair Ziekenhuis Leuven, Leuven, Belgium.
  • Goldhirsch A; Oncology Clinic, Istenhegyi Géndiagnosztika Private Health Center, Budapest, Hungary.
  • Di Leo A; Department of Medical Oncology, Bergonié Institute, Bordeaux, France.
  • Colleoni M; National Institute for Health Research Manchester Clinical Research Facility at the Christie National Health Service Foundation Trust, Manchester Academic Health Science Centre and Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, University of Manchest
  • Vaz-Luis I; International Breast Cancer Study Group and Swiss Group for Clinical Cancer Research, Bern, Switzerland.
  • Lin NU; European Institute of Oncology, IRCCS, Milan, Italy.
Cancer ; 127(5): 700-708, 2021 03 01.
Article en En | MEDLINE | ID: mdl-33290610
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Cancer Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Cancer Año: 2021 Tipo del documento: Article